Here are three insights.
1. Per the agreement, HIP will focus on delivering Xtant Medical’s global strategy, supporting current distribution partners, recruiting partners for new markets and assisting with country specific product registration.
2. HIP’s leadership is filled with senior international executives with more than 60 years of global expansion experience combined.
3. Xtant Medical specializes in regenerative medicine and medical devices. The company’s products are used to benefit orthopedic and neurosurgeons.
“Our partnership with HIP will allow Xtant to proliferate current channels, exploit untapped market opportunities and to enhance the levels of customer services we are able to provide internationally,” Xtant CEO Carl O’Connell said.
More articles on devices and implants:
1st spine surgery with SpineGuard’s PediGuard performed in China — 5 highlights
Stryker’s spine division to drive Q1 sales: 5 insights
Kineta Chronic Pain inks $360M+ deal with pharmaceutical giant: 3 things to know
